Incidence of Acute Kidney Injury With the Use of Nafcillin Versus Oxacillin

Alejandro D Perez1, Autumn L Brenner1, Emilia Pieta2

  • 1Department of Pharmacy, University of North Carolina, Medical Center, Chapel Hill, North Carolina, USA.

Pharmacotherapy
|April 18, 2026
PubMed
Abstract

Insights

Nafcillin is linked to a higher risk of acute kidney injury (AKI) compared to oxacillin in patients treated for Staphylococcus aureus infections. This study highlights important safety differences between these antistaphylococcal penicillins.

Area of Science:

  • Pharmacology and Nephrology
  • Infectious Diseases and Antibiotic Therapy

Background:

  • Antistaphylococcal penicillins (ASPs) like nafcillin and oxacillin are crucial for treating methicillin-susceptible Staphylococcus aureus (MSSA) infections.
  • Despite similar efficacy and pharmacokinetic profiles, emerging evidence suggests differing safety profiles, particularly concerning acute kidney injury (AKI).

Purpose of the Study:

  • To compare the incidence of AKI between nafcillin and oxacillin in adult inpatients.
  • To evaluate secondary outcomes including serum creatinine changes, AKI severity, and mortality.

Main Methods:

  • Retrospective cohort study of 638 adult inpatients receiving at least six doses of nafcillin or oxacillin.
  • Primary outcome: incidence of AKI during treatment.
  • Secondary outcomes: serum creatinine, AKI stage, duration of therapy/hospitalization, mortality, hypokalemia, and hepatotoxicity.

Main Results:

  • AKI occurred in 33.3% of nafcillin patients versus 19.5% of oxacillin patients (adjusted risk ratio 1.55, p < 0.01).
  • Nafcillin was associated with higher AKI incidence across all stages, longer hospitalizations, increased mortality, and greater rates of hypokalemia.
  • Exploratory outcomes also indicated higher rates of moderate and severe hypokalemia with nafcillin.

Conclusions:

  • Nafcillin treatment is associated with a significantly higher incidence of AKI compared to oxacillin.
  • These findings underscore critical safety distinctions between nafcillin and oxacillin, informing clinical decision-making for MSSA infections.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
525
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.4K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.1K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K